Tysabri ® (natalizumab) Biogen Idec Inc. BLA 125104 /15
Tysabri ® (natalizumab) Biogen Idec Inc. BLA 125104 /15. Peripheral and Central Nervous System Drugs Advisory Committee Gaithersburg, Maryland March 7-8, 2006 Susan S. McDermott, M.D. Division of Neurology Products. Center for Drug Evaluation and Research. Review of Efficacy and PML.
478 views • 14 slides